This is a news story, published by Yahoo, that relates primarily to Rybelsus news.
For more Rybelsus news, you can click here:
more Rybelsus newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
diabetes drugs Ozempic. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest prescription news, prescriptions news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
popular prescription drugsUSA Today
•87% Informative
New research shows a 442% increase in prescriptions for semaglutide between January 2021 and December 2023 .
Ozempic, Rybelsus and Wegovy are popular diabetes and weight-loss drugs that treat diabetes, obesity and heart disease.
Patients with private insurance are more likely to have their prescriptions filled than Medicare and Medicaid patients.
Medicare is prohibited by law from covering drugs for obese people.
VR Score
89
Informative language
91
Neutral language
35
Article tone
formal
Language
English
Language complexity
58
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
13
Source diversity
10
Affiliate links
no affiliate links